Circulating sCD36 is associated with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals

Impact of obesity and insulin-resistance on cirrhosis and portal hypertension

(2013) Annalisa Berzigotti et al.   Gastroenterologia y Hepatologia

Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease

(2013) Melania Gaggini et al.   Nutrients

Dyslipidemia in Obesity: Mechanisms and Potential Targets

(2013) Boudewijn Klop et al.   Nutrients

Fatty acid transporters involved in the palmitate and oleate induced insulin resistance in primary rat hepatocytes

(2012) A. Chabowski et al.   Acta Physiologica

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass

(2012) C. Dirksen et al.   DIABETOLOGIA

CD36 level and trafficking are determinants of lipolysis in adipocytes

(2012) Dequan Zhou et al.   FASEB JOURNAL

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

(2012) Naga Chalasani et al.   GASTROENTEROLOGY

High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C

(2012) S. Petta et al.   JOURNAL OF VIRAL HEPATITIS

Role of the Gut in Lipid Homeostasis

(2012) Nada A. Abumrad et al.   PHYSIOLOGICAL REVIEWS

Scavenger Receptor CD36 Expression Contributes to Adipose Tissue Inflammation and Cell Death in Diet-Induced Obesity

(2012) Lei Cai et al.   PLoS One

From excess adiposity to insulin resistance: The role of free fatty acids

(2012) Cristiano Capurso et al.   VASCULAR PHARMACOLOGY

Ectopic Fat and Insulin Resistance: Pathophysiology and Effect of Diet and Lifestyle Interventions

(2012) M. Snel et al.   International Journal of Endocrinology

Hepatic Steatosis in Morbidly Obese Patients Undergoing Gastric Bypass Surgery: Assessment With Open-System 1H-MR Spectroscopy

(2011) Jochem R. van Werven et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Triglycerides and Cardiovascular Disease

(2011) Michael Miller et al.   CIRCULATION

CD36 genetics and the metabolic complications of obesity

(2011) Latisha Love-Gregory et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C

(2011) M. E. Miquilena-Colina et al.   GUT

Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease

(2011) Romina Lomonaco et al.   HEPATOLOGY

Changes in Glucose Homeostasis after Roux-en-Y Gastric Bypass Surgery for Obesity at Day Three, Two Months, and One Year after Surgery: Role of Gut Peptides

(2011) Y. Falkén et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population

(2011) A. Handberg et al.   JOURNAL OF INTERNAL MEDICINE

Obesity, insulin resistance and free fatty acids

(2011) Guenther Boden   Current Opinion in Endocrinology Diabetes and Obesity

Soluble CD36− a marker of the (pathophysiological) role of CD36 in the metabolic syndrome?

(2011) Debby P.Y. Koonen et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Relation of C-Reactive Protein to Abdominal Adiposity

(2010) Gabriel C. Brooks et al.   AMERICAN JOURNAL OF CARDIOLOGY

Liver Fat in the Pathogenesis of Insulin Resistance and Type 2 Diabetes

(2010) Hannele Yki-Järvinen   DIGESTIVE DISEASES

Soluble CD36 (sCD36) Clusters with Markers of Insulin Resistance, and High sCD36 Is Associated with Increased Type 2 Diabetes Risk

(2010) A. Handberg et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Increased Circulating and Visceral Adipose Tissue Expression Levels of YKL-40 in Obesity-Associated Type 2 Diabetes Are Related to Inflammation: Impact of Conventional Weight Loss and Gastric Bypass

(2010) Victoria Catalán et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis

(2009) Henry Buchwald et al.   AMERICAN JOURNAL OF MEDICINE

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes

(2009) Camilla N Rathcke et al.   Cardiovascular Diabetology

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

Circulating soluble CD36 is associated with glucose metabolism and interleukin-6 in glucose-intolerant men

(2009) Aase Handberg et al.   Diabetes & Vascular Disease Research

Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors

(2009) Anna Kotronen et al.   GASTROENTEROLOGY

YKL-40 is Elevated in Morbidly Obese Patients and Declines After Weight Loss

(2009) Moritz Hempen et al.   OBESITY SURGERY

Emerging role of adipose tissue hypoxia in obesity and insulin resistance

(2008) J Ye   INTERNATIONAL JOURNAL OF OBESITY

Soluble CD36 in Plasma Is Increased in Patients With Symptomatic Atherosclerotic Carotid Plaques and Is Related to Plaque Instability

(2008) Aase Handberg et al.   STROKE